As an experienced exporter in to Western Europe and Northern America, Cambridge Research Biochemicals (CRB) is now looking to pastures new for future business growth.
UKTI (UK Trade & Investment) are hosting Asia-Pacific Life Science Clinics (in their 5th year) all week up and down the country and we were fortunate to attend the one-to-one meetings yesterday in Newcastle.
The Asia-Pacific is the world’s fastest growing economic region and although it takes a minimum of 12 hours to get there from the UK, it offers great opportunities for specialist businesses like ourselves to offer our great British expertise.
Although the Japanese Trade Officer was unavailable, within 1 day we were able to hold informative meetings with experts from China, Singapore, Taiwan, South Korea, Australia and New Zealand. It really did feel like we had travelled to the other side of the world and after six back to back meetings felt quite jet lagged!
I would certainly recommend such clinics and it was wonderful to be visited by so many South East Asian representatives in one room and their knowledge of the Life Sciences and Biotechnology Sector is good. In 2013, we will be making several trips to the South East Asian continent starting with a Life Science UKTI tour to Japan in February 2013.
Cambridge Research Biochemicals (CRB) expects to increase it’s current South East Asian connections more aggressively over the next 3 years. The company to date has an agent, Biobridge in Japan and distributes on behalf of Panagene (South Korea).
Cambridge Research Biochemicals has appointed Kenny Lang (Business Associate) to set up several agents in China and is working closely with Sharon Eaton (BioChannel) to identify the most suitable partners in China to promote Cambridge Research Biochemicals’ specialist Laboratory tool reagents business of Custom Peptides and Custom Antibodies.
Emily Humphrys, Commercial Director Cambridge Research Biochemicals